Off-label, and off the mark
The trumpeting of hydroxychloroquine's potential in treating COVID-19 raises ethical and safety concerns.
Remaining model citizens
While we've so far successfully contained COVID-19, the modelling clearly shows now isn't the time to relax many of the restrictions.
Demystifying the curve
Epidemiological models may be complex, but they must be treated with respect.
What price a person?
Rather than basing decisions about ICU access on age, clinicians need to consider the potential benefits and burdens of treatments proposed for every patient.
A road more travelled
With many people now house-bound, internet problems that were annoying for typical domestic users have become major impediments to working from home.
Perfect storm: How fake news can be fatal
The spread of misinformation has striking parallels with the biological pandemic – and it, too, has cost lives.
Professor, Centre for Medicine Use & Safety
Senior Research Fellow, Drug Delivery Disposition and Dynamics, Faculty of Pharmacy and Pharmaceutical Sciences
Research Fellow, Department of Infectious Diseases, The Alfred, and Central Clinical School
Lecturer, Data Science and Artificial Intelligence
Research Fellow, Software Systems and Cybersecurity, Faculty of IT
Professor of Medicine